Table 4 Haemostatic parameters with ECMO
Variables | All patients (n = 51) | Control group (n = 24) | Protocol group (n = 27) | p |
|---|---|---|---|---|
ECMO implantationa | ||||
Fibrinogen, g/l | 7.3 [5.4–8] | 7.6 [5.8–8.6] | 6.8 [4.8–7.9] | 0.29 |
Platelet count, G/l | 264 [197–332] | 273 [198–350] | 261 [196–311] | 0.5 |
During ECMO support | ||||
Lowest fibrinogen, g/L | 3.5 [2.6–4.6] | 3.8 [3–5.1] | 3.1 [2.3–4.4] | 0.05 |
Lowest platelet count, G/L | 111 [63–166] | 113 [66–165] | 110 [62–171] | 0.78 |
Median anti-Xa on ECMO, IU/L | 0.36 [0.28–0.43] | 0.39 [0.31–0.48] | 0.32 [0.26–0.38] | 0.06 |
Number of day with an anti-Xa > 0.7 IU/L | 1 [0–1] | 0 [0–1] | 1 [0–1] | 0.4 |
Lowest PT, % | 57 [47–64] | 56 [44–63] | 57 [49–70] | 0.36 |